Onkologie. 2017:11(1):29-33 | DOI: 10.36290/xon.2017.007
Rational use of psychotropic drugs in oncology – selected indications, interactions, tips for practice
- 1Oddělení klinické farmacie, Nemocnice Na Bulovce, Praha, 2Ústav aplikované farmacie, Farmaceutická fakulta VFU, Brno, 3Ústav radiační onkologie, Nemocnice Na Bulovce, Praha, 4 1. Lékařská fakulta UK, Praha
Indications psychotropic drugs in oncology include also chemotherapyinduced
neuropathy, delirium, nausea, emesis and affect
appetite. Psychotropic drugs are often used "off label" and should be used in patients to attention. Levels of some of psychotropic
drugs may be affected by a number of concomitantly administered drugs due to pharmacokinetic drug interactions. Dexamethasone,
phenytoin, and carbamazepine are often the comedication
with the abovementioned
indications, among the important
enzyme inducers and may reduce the effect of psychotropic drugs. Combinations of psychotropics potentially increased risk of
pharmacodynamic drug interactions.
Keywords: psychotropic drugs, onkology, drug interaction
Published: February 1, 2017 Show citation
References
- Hershman DL, Lacchetti CH, et al. Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2014; 32: 1941-1967.
Go to original source... 
Go to PubMed... - Breitbart W, Alici Y. Evidence-Based Treatment of Delirium in Patients With Cancer. J Clin Oncol. 2012; 30: 1206-1214. Go to original source... Go to PubMed...
- Yoon HJ, Park KM, et al. Efficacy and safety of haloperidol versus atypical antipsychotic medications in the treatment of delirium. BMC Psychiatry. 2013; 13: 240. Go to original source... Go to PubMed...
- Gordon P, LeGrand SB, et al. Nausea and vomiting in advanced cancer. European Journal of Pharmacology 2014; 722: 187-191. Go to original source... Go to PubMed...
- Glare P, Miller J, Nikolova T, et al. Treating nausea and vomiting in palliative care: a review. Clinical Interventions in Aging. 2011; 6: 243-259. Go to original source... Go to PubMed...
- Hardy JR, O'Shea A, et al. The efficacy of haloperidol in the management of nausea and vomiting in patients with cancer. J Pain Symptom Manage. 2010; 40(1): 111-116. Go to original source... Go to PubMed...
- Prommer E. Role of haloperidol in palliative medicine: an update. Am J Hosp Palliat Care. 2012; 29(4): 295-301. Go to original source... Go to PubMed...
- Navari RM, Gray SE, et al. Olanzapine versus aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a randomized phase III trial. J Support Oncol. 2011; 9(5): 188-195. Go to original source... Go to PubMed...
- Navari RM, Nagy CK, et al. The use of olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy. Support Cate Cancer. 2013; 21(6): 1655-1663. Go to original source... Go to PubMed...
- Fujáková M, Kopeček M. Antidepresiva - od teorie ke klinické praxi. Klin Farmakol Farm 2012; 26(1): 29-37.
- Prokeš M, Suchopár J. Lékové interakce v psychiatrii - teorie a praxe. Psychiatrie pro praxi. 2015; 16(2): 51-56.
- Wojcikowski J, Basinska A, et al. The influence of amitriptyline and carbamazepine on levomepromazine metabolism in human liver: An in vitro study. Pharmacological Reports. 2014; 66: 1122-1126. Go to original source... Go to PubMed...